“Therapeutic Approach With PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes”. Cardiology and Cardiovascular Medicine 4, no. 6 (December 3, 2020): 736–742. Accessed September 18, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/15983.